IN CASE YOU MISSED IT: Recently, News Medical Life Sciences reported on a new study by the RAND Corporation that found biosimilar competition in the pharmaceutical marketplace could lower drug prices for numerous medications and lead to $38.4 billion in savings from 2021 to 2025. “This report underlines the increased need for biosimilar competition in the U.S. healthcare […]

Continue Reading

WHAT YOU NEED TO KNOW: New Year, New Ways to Strengthen the U.S. Patent System For too long, some of the largest drug manufacturers have utilized low-quality patents to block market entry of affordable generic alternatives in order to extend exclusivity of their brand name drugs. To combat these anticompetitive tactics, reforms such as the America […]

Continue Reading